GRANDI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 10.908
AS - Asia 6.966
EU - Europa 4.672
SA - Sud America 1.080
AF - Africa 212
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.883
Nazione #
US - Stati Uniti d'America 10.677
SG - Singapore 2.277
CN - Cina 1.783
IT - Italia 1.077
GB - Regno Unito 1.030
HK - Hong Kong 976
BR - Brasile 825
VN - Vietnam 739
SE - Svezia 503
DE - Germania 459
FI - Finlandia 328
RU - Federazione Russa 314
KR - Corea 229
FR - Francia 194
UA - Ucraina 157
IN - India 141
ID - Indonesia 117
NL - Olanda 117
TR - Turchia 115
BD - Bangladesh 113
AR - Argentina 100
BG - Bulgaria 98
CA - Canada 92
MX - Messico 83
IQ - Iraq 78
ES - Italia 65
JP - Giappone 59
PL - Polonia 58
ZA - Sudafrica 51
AU - Australia 40
PK - Pakistan 38
LT - Lituania 37
CO - Colombia 36
MY - Malesia 36
IE - Irlanda 34
EC - Ecuador 31
MA - Marocco 28
PH - Filippine 26
ET - Etiopia 25
AE - Emirati Arabi Uniti 24
IL - Israele 24
AT - Austria 23
CL - Cile 23
UZ - Uzbekistan 23
VE - Venezuela 22
KE - Kenya 19
SA - Arabia Saudita 19
SI - Slovenia 17
TN - Tunisia 17
IR - Iran 16
KZ - Kazakistan 15
CH - Svizzera 14
DZ - Algeria 14
PY - Paraguay 14
EG - Egitto 13
JO - Giordania 13
PT - Portogallo 13
BE - Belgio 12
BO - Bolivia 12
IS - Islanda 12
RS - Serbia 12
AZ - Azerbaigian 11
NP - Nepal 11
RO - Romania 11
DO - Repubblica Dominicana 10
SN - Senegal 10
TH - Thailandia 10
CZ - Repubblica Ceca 9
GR - Grecia 9
HR - Croazia 9
PA - Panama 9
TW - Taiwan 9
AL - Albania 8
PE - Perù 8
BY - Bielorussia 7
CR - Costa Rica 7
DK - Danimarca 7
HU - Ungheria 7
LV - Lettonia 7
MD - Moldavia 7
OM - Oman 7
QA - Qatar 7
UY - Uruguay 7
AM - Armenia 6
BH - Bahrain 6
GE - Georgia 6
JM - Giamaica 6
NO - Norvegia 6
CI - Costa d'Avorio 5
LB - Libano 5
SY - Repubblica araba siriana 5
CY - Cipro 4
HN - Honduras 4
KG - Kirghizistan 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
CG - Congo 3
CM - Camerun 3
GT - Guatemala 3
Totale 23.822
Città #
Santa Clara 1.467
Singapore 1.313
Ashburn 1.211
Hong Kong 955
Fairfield 880
Chandler 610
Hefei 501
San Jose 500
Southend 484
Woodbridge 453
Beijing 362
Seattle 350
Nyköping 330
Houston 328
Cambridge 325
London 305
Dallas 291
Wilmington 271
Helsinki 249
Ho Chi Minh City 246
Jacksonville 221
Seoul 221
Los Angeles 212
Dearborn 207
The Dalles 188
Ann Arbor 187
Hanoi 170
Chicago 165
Modena 154
New York 138
Princeton 115
Milan 108
Council Bluffs 107
Lauterbourg 99
Sofia 95
San Diego 93
Moscow 87
Rome 78
Munich 75
Jakarta 72
Shanghai 72
Salt Lake City 70
São Paulo 69
Bremen 68
Bologna 66
Buffalo 61
Eugene 55
Belo Horizonte 44
Tokyo 44
Orem 43
Amsterdam 40
Izmir 40
Baghdad 39
Warsaw 38
Dublin 34
Chennai 32
Da Nang 32
Frankfurt am Main 32
Columbus 31
Haiphong 30
Stockholm 30
Redondo Beach 29
Brooklyn 28
Mexico City 26
Guangzhou 25
Kent 25
Turku 25
Elk Grove Village 24
Manchester 24
Denver 23
Montreal 23
Phoenix 21
Redwood City 21
Atlanta 20
Johannesburg 20
Nuremberg 20
Tashkent 20
Cardiff 19
Düsseldorf 19
San Francisco 19
Tampa 19
Dronten 18
Madrid 18
Norwalk 18
Rio de Janeiro 18
Lappeenranta 17
Miami 17
Naples 16
Portsmouth 16
Toronto 16
Buenos Aires 15
Campinas 15
Lahore 15
Orsogna 15
San Mateo 15
Schiffdorf 15
Dhaka 14
Falls Church 14
Lille 14
Nairobi 14
Totale 15.943
Nome #
Intensity of menstrual pain and estimated angle of uterine flexion 408
Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle? 407
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 370
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 328
Association between urinary incontinence and climacteric symptoms in postmenopausal women 316
Intermenstrual pelvic pain, quality of life and mood 313
A regional audit system for stillbirth: A way to better understand the phenomenon 312
Adenomyosis of the Extrapelvic Portion of the Round Ligament 309
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 298
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 296
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 294
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 292
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 284
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 282
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 280
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 280
Metabolic impact of combined hormonal contraceptives containing estradiol 277
Levonorgestrel-releasing intra-uterine systems as female contraceptives 275
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 275
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 274
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 273
Vaginal alpha-lipoic acid shows an anti-inflammatory effect on the cervix, preventing its shortening after primary tocolysis. A pilot, randomized, placebo-controlled study 270
Pharmacokinetic evaluation of desogestrel as a female contraceptive 268
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study 268
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 259
The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa 258
Induction of Labor According to Medical Indications: A Critical Evaluation through a Prospective Study 258
Combined hormonal contraceptives in BRCA gene mutation carriers: why not? 257
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 254
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 249
Hormonal contraception in women with endometriosis: a systematic review 249
The Association of Four Natural Molecules-EGCG, Folic Acid, Vitamin B12, and HA-To Counteract HPV Cervical Lesions: A Case Report 246
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 244
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 241
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis 237
Prevalence of menstrual pain in young women: What is dysmenorrhea? 236
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 225
Hereditary ovarian cancers: State of the art 224
Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study 219
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study 214
Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis 213
Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting 210
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 204
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study 203
A first trimester prediction model for large for gestational age infants: a preliminary study 202
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 199
Dienogest mediates midkine suppression in endometriosis 198
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 198
Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception 197
Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause? 196
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes 193
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review 189
A 10-year report from a multicentre randomised controlled trial: Immediate non-occlusal versus early loading of dental implants in partially edentulous patients 189
The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study 188
Attitudes towards menstruation: what women want? An Italian National Survey 187
A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns 186
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism 186
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM) 184
Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics 180
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 179
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report 176
A comparison of two implants with conical vs internal hex connections: 1-year post-loading results from a multicentre, randomised controlled trial 175
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning 174
Use of hormonal contraception in italian university students 160
Soluzioni di design per viti di connessione implantare: studio agli elementi finiti. 160
Estetrol (E4): the new estrogenic component of combined oral contraceptives 157
Breast cancer screening of mutation carriers in the era of COVID-19 pandemic 155
Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials 152
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception 152
Contraception and Cardiovascular Diseases 151
Eziologia del dolore pelvico cronico e qualità di vita. 150
Estradiol in non-oral hormonal contraception: a “long and winding road” 150
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations 149
The drospirenone (DRSP)-only pill: clinical implications in the daily use 148
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? 148
Contraception During Perimenopause: Practical Guidance 147
Laparoscopic management of ectopic pregnancies: a comparison between interstitial and “more distal” tubal pregnancies 144
Implant site preparation using a single bur versus multiple drilling steps: 4-month post-loading results of a multicenter randomised controlled trial 144
Hormonal Contraception in perimenopausal women 142
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy? 139
The impact of epidural analgesia on delivery mode in Robson class 1 women: a retrospective cohort study 135
A 3-year report from a multicentre randomised controlled trial: Immediately versus early loaded implants in partially edentulous patients 135
Prevalenza e caratteristiche del dolore mestruale in giovani donne 133
Trattamento medico dell'endometriosi: progestinici e formulazioni estro-progestiniche 133
The use of a pill containing ethinylestradiol-norgestimate improves female sexuality despite the decrease in circulating androgens: a pilot study 133
Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis 128
Wide diameter immediate post-extractive implants vs delayed placement of normal-diameter implants in preserved sockets in the molar region: 1-year post-loading outcome of a randomised controlled trial 128
Immediate loading of two unsplinted implants retaining the existing complete mandibular denture in elderly edentulous patients: 1-year results from a multicentre prospective cohort study 127
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA 124
Immediate, early (3 weeks) and conventional loading (4 months) of single implants: Preliminary data at 1 year after loading from a pragmatic multicenter randomised controlled trial 124
Clinical outcome and bone healing of implants placed with high insertion torque: 12-month results from a multicenter controlled cohort study 122
It is time to talk about replacement of subdermal implants from the same cut, is it always feasible? The slow process of the "armpit approach" 121
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome 120
Molecole di adesione tissutale ed endometriosi 120
Lipid metabolism, insulin resistance, blood pressure and body composition with oral contraceptives containing astradiol valerato/dienogest vs ethinylestradiol/chlormadinone: a prospective, randomized trial. 120
Postpartum contraception: A matter of guidelines 119
Fattori di rischio cardiovascolare, dolore mestruale e qualità di vita con contraccettivi orali contenenti estradiolo valerato/dienogest vs etinilestradiolo/clormadinone acetato: trial prospettico, randomizzato. 116
Miglioramento della qualità di vita con contraccettivo orale in donne affette da dismenorrea primaria 115
Prevalenza e fattori di rischio di dismenorrea in studentesse universitarie italiane 114
TNFα-induced IKKβ complex activation influences epithelial, but not stromal cell survival in endometriosis 114
Totale 20.554
Categoria #
all - tutte 103.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 0 0 0 0 0 132 197
2021/20221.521 171 97 77 37 42 131 34 74 250 156 225 227
2022/20231.880 268 253 133 136 212 251 40 145 218 36 96 92
2023/20241.557 66 83 58 149 257 125 152 212 99 79 103 174
2024/20255.255 135 79 77 364 1.026 758 320 277 680 398 508 633
2025/20269.471 684 405 1.078 1.059 1.356 658 1.340 526 1.161 988 216 0
Totale 24.107